HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 101 filers reported holding HARVARD BIOSCIENCE INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,938,857 | -54.9% | 450,897 | -42.5% | 0.18% | -52.5% |
| Q2 2023 | $4,301,915 | -1.8% | 783,591 | -24.9% | 0.38% | -8.6% |
| Q1 2023 | $4,382,893 | +50.1% | 1,043,546 | -1.0% | 0.42% | +43.8% |
| Q4 2022 | $2,920,411 | -15.0% | 1,054,300 | -21.4% | 0.29% | -20.1% |
| Q3 2022 | $3,436,000 | -61.1% | 1,342,091 | -45.3% | 0.36% | -59.2% |
| Q2 2022 | $8,827,000 | -43.7% | 2,451,861 | -3.0% | 0.89% | -28.9% |
| Q1 2022 | $15,691,000 | -12.3% | 2,526,789 | -0.5% | 1.25% | +3.9% |
| Q4 2021 | $17,899,000 | +8.7% | 2,538,799 | +7.7% | 1.20% | +0.3% |
| Q3 2021 | $16,459,000 | +8.7% | 2,358,010 | +29.7% | 1.20% | +10.2% |
| Q2 2021 | $15,143,000 | +72.2% | 1,817,877 | +12.9% | 1.09% | +57.6% |
| Q1 2021 | $8,795,000 | +53.1% | 1,610,813 | +20.3% | 0.69% | +32.4% |
| Q4 2020 | $5,745,000 | +94.9% | 1,339,182 | +36.8% | 0.52% | +56.8% |
| Q3 2020 | $2,947,000 | +64.1% | 979,067 | +69.0% | 0.33% | +62.4% |
| Q2 2020 | $1,796,000 | – | 579,294 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
| Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
| Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
| Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
| BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
| DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
| Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
| HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
| Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |